Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

BBOTBridgeBio Oncology Therapeutics, Inc.

Nasdaq · CIK 0001869105
Filer categoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts253

Identity from submissions API

NameBridgeBio Oncology Therapeutics, Inc.
CIK0001869105
TickersBBOT
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SIC2834 Pharmaceutical Preparations
EIN000000000
LEI—
Fiscal year end1231
State of incorporationDE DE
Phone857 702 0377
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Helix Acquisition Corp. II (2023-12-20T00:00:00.000Z → 2025-08-06T00:00:00.000Z)
Business address
256 E. GRAND AVENUE, SUITE 104
SOUTH SAN FRANCISCO
CA
94080
CA
Mailing address
256 E. GRAND AVENUE, SUITE 104
SOUTH SAN FRANCISCO
CA
94080
CA

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

192 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-20 4 4 0001193125-26-470272 5423
2026-11-18 144 xsl144X01/primary_doc.xml 0001950047-26-011312 001-41955 261571063 33 5004
2026-11-17 4 4 0001193125-26-465625 4914
2026-11-13 144 xsl144X01/primary_doc.xml 0001950047-26-011075 001-41955 261552955 33 4890
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0001193805-26-001463 005-94447 261551907 34 22246
2026-11-10 10-Q 10-Q 0001193125-26-455521 001-41955 261540673 34 11993927 1 1
2026-11-10 8-K 8-K 2.02,9.01 0001193125-26-455506 001-41955 261540630 34 411117 1 1
2026-11-05 8-K 8-K 5.02 0001193125-26-449722 001-41955 261527006 34 140527 1 1
2026-10-23 4 4 0001193125-26-430449 5007
2026-10-05 4 4 0001193125-26-414135 5007
2026-10-05 4 4 0001193125-26-414131 4981
2026-10-05 4 4 0001193125-26-414127 5031
2026-10-05 4 4 0001193125-26-414123 5032
2026-09-14 4 4 0001193125-26-390624 9177
2026-09-10 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002939 333-298697 261372606 33 1883
2026-09-08 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002909 333-289940 261366515 33 1896
2026-09-08 8-K 8-K 8.01,9.01 0001193125-26-385225 001-41955 261365306 34 4978771 1 1
2026-09-01 S-3 S-3 0001193125-26-378637 333-298697 261351803 33 1654277 1 1
2026-09-01 POS AM POS AM 0001193125-26-378366 333-289940 261350797 33 984475 1 1
2026-08-12 424B3 424B3 0001193125-26-345123 333-289940 261264612 33 2825317
2026-08-11 10-Q 10-Q 0001193125-26-344661 001-41955 261263323 34 10795601 1 1
2026-08-11 8-K 8-K 2.02,9.01 0001193125-26-344608 001-41955 261263194 34 416800 1 1
2026-07-06 4 4 0001193125-26-296504 5005
2026-07-06 4 4 0001193125-26-296503 4980
2026-07-06 4 4 0001193125-26-296502 5031
2026-07-06 4 4 0001193125-26-296501 5030
2026-07-06 SCHEDULE 13D/A xslSCHEDULE_13D_X02/primary_doc.xml 0001213900-26-075546 005-94447 261156449 34 50819
2026-07-06 4 xslF345X06/ownership.xml 0001213900-26-075538 13599
2026-06-22 424B3 424B3 0001193125-26-277572 333-289940 261107438 33 27795
2026-06-22 8-K 8-K 5.02,5.07 0001193125-26-277513 001-41955 261107030 34 148291 1 1
2026-06-18 4 4 0001193125-26-276050 16327
2026-06-18 4 4 0001193125-26-276048 16336
2026-06-18 4 4 0001193125-26-276046 16315
2026-06-18 4 4 0001193125-26-276043 5678
2026-06-18 4 4 0001193125-26-276041 5615
2026-06-18 4 4 0001193125-26-276035 16318
2026-06-18 4 4 0001193125-26-276033 16323
2026-05-13 424B3 424B3 0001193125-26-221560 333-289940 26973089 33 2287025
2026-05-12 10-Q 10-Q 0001193125-26-219829 001-41955 26969794 34 12727998 1 1
2026-05-12 8-K 8-K 2.02,9.01 0001193125-26-219801 001-41955 26969743 34 390198 1 1
2026-05-12 4 4 0001193125-26-219447 5627
2026-05-12 4 4 0001193125-26-219439 15630
2026-05-06 424B3 424B3 0001193125-26-208937 333-289940 26948308 33 8636606
2026-05-05 4 4 0001193125-26-207041 5017
2026-05-05 4 4 0001193125-26-207035 5030
2026-05-05 4 4 0001193125-26-207031 5074
2026-05-04 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001459 333-289940 26940142 33 1895
2026-04-30 POS AM POS AM 0001193125-26-197901 333-289940 26927389 33 21332375 1 1
2026-04-30 3 3 0001193125-26-197373 17041
2026-04-30 3 3 0001193125-26-197346 19540
2026-04-29 424B3 424B3 0001193125-26-191533 333-289940 26916008 33 24542
2026-04-29 8-K 8-K 5.02 0001193125-26-191512 001-41955 26915868 34 144126 1 1
2026-04-28 ARS ARS 0001193125-26-187049 001-41955 26907863 34 25527784
2026-04-28 DEFA14A DEFA14A 0001193125-26-186995 001-41955 26907732 34 793698
2026-04-28 DEF 14A DEF 14A 0001193125-26-186944 001-41955 26907647 34 1556527 1 1
2026-04-23 424B3 424B3 0001193125-26-170973 333-289940 26884920 33 36436
2026-04-23 8-K 8-K 5.02,7.01,9.01 0001193125-26-170888 001-41955 26884859 34 184337 1 1
2026-03-26 4 4 0001193125-26-126602 5565
2026-03-26 3 3 0001193125-26-126590 26924
2026-03-26 424B3 424B3 0001193125-26-126508 333-289940 26799071 33 24521
2026-03-26 8-K 8-K 5.02 0001193125-26-126493 001-41955 26799049 34 143351 1 1
2026-03-12 4 4 0001193125-26-104384 7425
2026-03-12 4 4 0001193125-26-104379 7448
2026-03-12 4 4 0001193125-26-104369 7441
2026-03-06 424B3 424B3 0001193125-26-094856 333-289940 26728370 33 5393275
2026-03-05 10-K 10-K 0001193125-26-094112 001-41955 26726858 34 16114885 1 1
2026-03-05 8-K 8-K 2.02,9.01 0001193125-26-093997 001-41955 26726341 34 784946 1 1
2026-01-07 424B3 424B3 0001193125-26-005435 333-289940 26513963 33 68672
2026-01-07 424B3 424B3 0001193125-26-005428 333-289940 26513956 33 1386788
2026-01-07 8-K 8-K 8.01,9.01 0001193125-26-005425 001-41955 26513951 34 197136 1 1
2026-01-05 4 4 0001193125-26-003027 5591
2026-01-02 S-8 S-8 0001193125-26-000904 333-292555 26502316 33 190314 1 1
2025-12-12 4 4 0001193125-25-317962 5977
2025-11-14 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-112512 005-94447 251486104 34 18542
2025-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0000902664-25-004881 005-94447 251475728 34 12573
2025-11-12 10-Q 10-Q 0001193125-25-277834 001-41955 251473845 34 10836226 1 1
2025-11-12 8-K 8-K 2.02,9.01 0001193125-25-277601 001-41955 251472858 34 211411 1 1
2025-10-16 4 4 0001193125-25-241634 8243
2025-10-10 S-8 S-8 0001193125-25-237057 333-290825 251388083 33 368132 1 1
2025-10-06 4 4 0001193125-25-231917 5553
2025-09-10 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002915 333-289940 251307155 33 1883
2025-09-10 424B3 424B3 0001193125-25-200153 333-289940 251306414 33 9141958
2025-09-08 CORRESP filename1.htm 0001193125-25-198323 6615
2025-09-03 UPLOAD filename1.pdf 0000000000-25-009499 333-289940 40293
2025-09-03 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002013681-25-000001 005-94447 251289114 34 11526
2025-08-29 S-1 S-1 0001193125-25-192760 333-289940 251280906 33 19931203 1 1
2025-08-28 4 4 0000950170-25-112020 6025
2025-08-28 4 4 0000950170-25-112016 6045
2025-08-28 4 4 0000950170-25-112008 6043
2025-08-28 4 4 0000950170-25-112003 6148
2025-08-28 4 4 0000950170-25-111997 6141
2025-08-28 4 4 0000950170-25-111992 6148
2025-08-28 4 4 0000950170-25-111986 5549
2025-08-19 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002673 333-288222 251233714 33 1896
2025-08-18 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0001193805-25-001205 005-94447 251229081 34 21359
2025-08-18 SCHEDULE 13D xslSCHEDULE_13D_X01/primary_doc.xml 0001193125-25-182790 005-94447 251229021 34 61142
2025-08-18 3 3 0000950170-25-109847 27711
2025-08-18 3 3 0000950170-25-109846 25067
2025-08-18 3 3 0000950170-25-109843 27716
2025-08-18 3 3 0000950170-25-109842 9335
2025-08-18 3 3 0000950170-25-109841 25056
2025-08-18 3 3 0000950170-25-109835 25057
2025-08-18 3 3 0000950170-25-109834 27734
2025-08-18 3 3 0000950170-25-109828 27734
2025-08-18 3 3 0000950170-25-109824 25106
2025-08-18 3 3 0000950170-25-109822 27746
2025-08-15 POS AM POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-4 0001213900-25-076945 333-288222 251221939 33 4547469 1 1
2025-08-13 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-075307 005-94447 251209086 34 36550
2025-08-13 4 xslF345X05/ownership.xml 0001213900-25-075305 27097
2025-08-13 8-K CURRENT REPORT 1.01,2.01,3.02,3.03,4.01,5.01,5.02,5.03,5.05,5.06,7.01,8.01,9.01 0001213900-25-075190 001-41955 251208614 34 3443594 1 1
2025-08-11 3 xslF345X02/ownership.xml 0001213900-25-074387 3199
2025-08-11 4 xslF345X05/ownership.xml 0001213900-25-074383 3688
2025-08-11 4 xslF345X05/ownership.xml 0001213900-25-074379 3614
2025-08-11 4 xslF345X05/ownership.xml 0001213900-25-074375 8179
2025-08-11 4 xslF345X05/ownership.xml 0001213900-25-074368 8184
2025-08-11 4 xslF345X05/ownership.xml 0001213900-25-074364 8192
2025-08-06 8-K CURRENT REPORT 7.01,9.01 0001213900-25-072312 001-41955 251187471 34 214198 1 1
2025-08-04 425 CURRENT REPORT 0001213900-25-071396 001-41955 251181078 34 62298
2025-08-04 8-K CURRENT REPORT 5.07 0001213900-25-071392 001-41955 251181061 34 241544 1 1
2025-08-01 10-Q QUARTERLY REPORT 0001213900-25-070659 001-41955 251176828 34 3705559 1 1
2025-07-30 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001104659-25-072172 005-94447 251167267 34 19607
2025-07-24 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-098552 005-94447 251148385 34 17521
2025-07-22 424B3 PROSPECTUS SUPPLEMENT 0001213900-25-066296 333-288222 251138448 33 139469
2025-07-21 425 FORM 425 0001213900-25-065883 001-41955 251135761 34 21204
2025-07-11 425 CURRENT REPORT 0001213900-25-062956 001-41955 251117507 34 57049
2025-07-11 8-K CURRENT REPORT 7.01,9.01 0001213900-25-062955 001-41955 251117506 34 240553 1 1
2025-07-10 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002217 333-288222 251117424 33 2665
2025-07-10 424B4 PROSPECTUS 0001213900-25-062864 333-288222 251117063 33 49001758
2025-07-09 CORRESP filename1.htm 0001213900-25-062226 10185
2025-07-09 S-4/A REGISTRATION STATEMENT 0001213900-25-062224 333-288222 251112539 33 78612059 1 1
2025-07-01 CORRESP filename1.htm 0001213900-25-060460 34544
2025-07-01 S-4/A REGISTRATION STATEMENT 0001213900-25-060456 333-288222 251097361 33 78606599 1 1
2025-06-27 UPLOAD filename1.pdf 0000000000-25-006779 377-07895 46701
2025-06-20 CORRESP filename1.htm 0001213900-25-056324 21886
2025-06-20 S-4 REGISTRATION STATEMENT 0001213900-25-056321 333-288222 251062442 33 80802090 1 1
2025-06-11 UPLOAD filename1.pdf 0000000000-25-006146 377-07895 44729
2025-05-30 DRSLTR filename1.htm 0001213900-25-049565 63389
2025-05-30 DRS/A filename1.htm 0001213900-25-049554 377-07895 251012272 33 45371501
2025-05-15 10-Q QUARTERLY REPORT 0001213900-25-044424 001-41955 25955986 34 3584674 1 1
2025-05-13 UPLOAD filename1.pdf 0000000000-25-005054 377-07895 79806
2025-04-22 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-000396 005-94447 25856209 34 10604
2025-04-15 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0002052113-25-000302 005-94447 25840377 34 10625
2025-04-15 DRS filename1.htm 0001213900-25-031720 377-07895 25837437 33 39447043
2025-04-14 DRSLTR filename1.htm 0001213900-25-031721 24629
2025-03-11 10-K ANNUAL REPORT 0001213900-25-022387 001-41955 25725532 34 4604957 1 1
2025-03-06 425 FORM 425 0001213900-25-021210 001-41955 25715758 34 262512
2025-03-04 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001213900-25-020316 005-94447 25707429 34 33112
2025-03-03 425 CURRENT REPORT 0001213900-25-018999 001-41955 25693471 34 2596317 1 1
2025-03-03 8-K CURRENT REPORT 1.01,3.02,9.01 0001213900-25-018997 001-41955 25693469 34 3333698 1 1
2025-02-28 425 CURRENT REPORT 0001213900-25-018335 001-41955 25682807 34 20926467
2025-02-28 8-K CURRENT REPORT 7.01,9.01 0001213900-25-018334 001-41955 25682802 34 21159726 1 1
2025-02-11 3 xslF345X02/ownership.xml 0001213900-25-012280 4808
2025-02-10 4 xslF345X05/ownership.xml 0001213900-25-011813 7553
2025-02-10 4 xslF345X05/ownership.xml 0001213900-25-011810 7198
2025-02-10 8-K CURRENT REPORT 5.02,9.01 0001213900-25-011454 001-41955 25603513 34 268244 1 1
2024-11-14 10-Q QUARTERLY REPORT 0001213900-24-098483 001-41955 241463104 34 3409176 1 1
2024-11-14 SC 13G hlxb13gsep24.txt 0000080255-24-001487 005-94447 34 6591
2024-11-08 SC 13G kyg4444h1011_110824.txt 0002012383-24-003714 005-94447 241439853 34 13661
2024-10-22 SC 13G kyg4444h1011_102224.txt 0002012383-24-001286 005-94447 241386109 34 13649
2024-08-14 10-Q QUARTERLY REPORT 0001213900-24-068630 001-41955 241204406 34 3315953 1 1
2024-05-15 10-Q QUARTERLY REPORT 0001213900-24-043582 001-41955 24950398 34 2918535 1 1
2024-02-23 SC 13G HELIX ACQUISITION CORP. II 0000902664-24-001997 005-94447 24671692 34 101900
2024-02-23 SC 13G SC 13G 0001104659-24-027006 005-94447 24671033 34 132031
2024-02-20 SC 13D SCHEDULE 13D 0001213900-24-015480 005-94447 24655918 34 269352
2024-02-20 8-K CURRENT REPORT 8.01,9.01 0001213900-24-015329 001-41955 24653641 34 310204 1 1
2024-02-15 SC 13G HLXB_SC13G.htm 0001319244-24-000030 005-94447 24644032 34 95966
2024-02-14 8-K CURRENT REPORT 1.01,3.02,5.02,5.03,8.01,9.01 0001213900-24-013637 001-41955 24632316 34 1377351 1 1
2024-02-13 4 xslF345X05/ownership.xml 0001213900-24-013534 12124
2024-02-13 4 xslF345X05/ownership.xml 0001213900-24-013530 6116
2024-02-13 424B4 PROSPECTUS 0001213900-24-012731 333-276591 24621787 33 2872106
2024-02-09 3 xslF345X02/ownership.xml 0001213900-24-011795 4785
2024-02-09 3 xslF345X02/ownership.xml 0001213900-24-011792 8668
2024-02-09 3 xslF345X02/ownership.xml 0001213900-24-011788 6252
2024-02-08 EFFECT xslEFFECTX01/primary_doc.xml S-1,,2024-02-08 16:00:00 9999999995-24-000357 333-276591 24610970 33 1810
2024-02-08 S-1MEF REGISTRATION STATEMENT 0001213900-24-011781 333-276958 24610956 33 123127
2024-02-08 3 xslF345X02/ownership.xml 0001213900-24-011784 8833
2024-02-08 3 xslF345X02/ownership.xml 0001213900-24-011783 6585
2024-02-08 3 xslF345X02/ownership.xml 0001213900-24-011782 4777
2024-02-08 CERT 8A_cert_HLXB.pdf 0001354457-24-000051 001-41955 24608833 34 149262
2024-02-08 8-A12B FOR REGISTRATION OF CERTAIN CLASSES 0001213900-24-011457 001-41955 24607987 34 23129
2024-02-07 CORRESP filename1.htm 0001213900-24-011137 6453
2024-02-07 CORRESP filename1.htm 0001213900-24-011134 8981
2024-02-07 S-1/A REGISTRATION STATEMENT 0001213900-24-010676 333-276591 24601902 33 3034444
2024-02-06 CORRESP filename1.htm 0001213900-24-010681 36462
2024-02-06 UPLOAD filename1.pdf 0000000000-24-001426 377-07010 44064
2024-02-02 CORRESP filename1.htm 0001213900-24-009486 21739
2024-02-02 S-1/A REGISTRATION STATEMENT 0001213900-24-009481 333-276591 24589866 33 3670743
2024-01-23 UPLOAD filename1.pdf 0000000000-24-000906 377-07010 44472
2024-01-18 CORRESP filename1.htm 0001213900-24-004594 59738
2024-01-18 S-1 REGISTRATION STATEMENT 0001213900-24-004590 333-276591 24542858 33 4827826
2024-01-10 UPLOAD filename1.pdf 0000000000-24-000330 377-07010 52552
2023-12-20 DRS filename1.htm 0001213900-23-097208 377-07010 231500343 33 3457806

Latest XBRL company facts

One latest value per concept from companyfacts (253 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 80.25M 2026-11-05 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
dei EntityPublicFloat Entity Public Float USD 465.15M 2025-08-13 2025 FY 10-K 2026-03-05 0001193125-26-094112
ffd NetFeeAmt NetFeeAmt USD 69,050 2026-09-01 S-3 2026-09-01 0001193125-26-378637
ffd TtlFeeAmt TtlFeeAmt USD 69,050 2026-09-01 S-3 2026-09-01 0001193125-26-378637
ffd TtlOfferingAmt TtlOfferingAmt USD 500.00M 2026-09-01 S-3 2026-09-01 0001193125-26-378637
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-09-01 S-3 2026-09-01 0001193125-26-378637
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-09-01 S-3 2026-09-01 0001193125-26-378637
us-gaap AccountsAndOtherReceivablesNetCurrent Accounts and Other Receivables, Net, Current USD 155,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap AccountsPayableAndAccruedLiabilitiesCurrent Accounts Payable and Accrued Liabilities, Current USD 2.52M 2025-06-30 2025 Q2 10-Q 2025-08-01 0001213900-25-070659
us-gaap AccountsPayableAndOtherAccruedLiabilities Accounts Payable and Other Accrued Liabilities USD 9,687 2024-03-31 2024 Q1 10-Q 2024-05-15 0001213900-24-043582
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 10.26M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap AccretionAmortizationOfDiscountsAndPremiumsInvestments Accretion (Amortization) of Discounts and Premiums, Investments USD -454,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 5.27M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 1.78M 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044424
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 1.65M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -1.70M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 784.38M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap AdjustmentsToAdditionalPaidInCapitalMarkToMarket Adjustments to Additional Paid in Capital, Fair Value USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 1.06M 2024-01-01 2024-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 271,572 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0001213900-25-022387
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD 4.75M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD 22,096 2024-01-01 2024-03-31 2025 Q2 10-Q 2025-08-01 0001213900-25-070659
us-gaap AdministrativeFeesExpense Administrative Fees Expense USD 38,748 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-01 0001213900-25-070659
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 15.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap AllowanceForDoubtfulAccountsReceivable Accounts Receivable, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap AmortizationOfRegulatoryAsset Amortization of Regulatory Asset USD 343,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 12.58M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap AreaOfRealEstateProperty Area of Real Estate Property sqft 10,934 2024-11-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap Assets Assets USD 346.22M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap AssetsCurrent Assets, Current USD 208.33M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap AssetsHeldInTrustCurrent Assets Held-in-trust, Current USD 328 2025-06-30 2025 Q2 10-Q 2025-08-01 0001213900-25-070659
us-gaap AssetsHeldInTrustNoncurrent Assets Held-in-trust, Noncurrent USD 196.51M 2025-06-30 2025 Q2 10-Q 2025-08-01 0001213900-25-070659
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax USD 14,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax USD 1.71M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap AvailableForSaleDebtSecuritiesAmortizedCostBasis Debt Securities, Available-for-sale, Amortized Cost USD 240.55M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap BusinessCombinationContingentConsiderationLiability Business Combination, Contingent Consideration, Liability USD 0 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap Cash Cash USD 459,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 76.48M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap CashCashEquivalentsAndShortTermInvestments Cash, Cash Equivalents, and Short-term Investments USD 315.30M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 76.61M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -297.21M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 76.02M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2025-06-30 2025 Q2 10-Q 2025-08-01 0001213900-25-070659
us-gaap CommonStockCapitalSharesReservedForFutureIssuance Common Stock, Capital Shares Reserved for Future Issuance shares 16.67M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 500.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 80.23M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 80.23M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap CommonStockValue Common Stock, Value, Issued USD 8,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -134.45M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap ContractWithCustomerLiability Contract with Customer, Liability USD 22.20M 2024-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap ContributionOfProperty Contribution of Property USD 0 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-11 0001193125-26-344661
us-gaap ConversionOfStockAmountConverted1 Conversion of Stock, Amount Converted USD 0 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap ConversionOfStockSharesConverted1 Conversion of Stock, Shares Converted shares 38.92M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap DebtInstrumentConvertibleConversionRatio1 Debt Instrument, Convertible, Conversion Ratio pure 0.089 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap DebtInstrumentRedemptionPricePercentage Debt Instrument, Redemption Price, Percentage pure 0.08 2025-08-01 2025-08-31 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap DebtSecuritiesAvailableForSaleAllowanceForCreditLoss Debt Securities, Available-for-sale, Allowance for Credit Loss USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap DeferredCompensationLiabilityClassifiedNoncurrent Deferred Compensation Liability, Classified, Noncurrent USD 5.52M 2024-03-31 2024 Q1 10-Q 2024-05-15 0001213900-24-043582
us-gaap DeferredCosts Deferred Costs, Noncurrent USD 332,894 2023-12-31 2024 FY 10-K 2025-03-11 0001213900-25-022387
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD 0 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 2.52M 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 87.88M 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 32.24M 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 700,000 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 42.73M 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 129.80M 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 825,000 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap DeferredTaxAssetsPropertyPlantAndEquipment Deferred Tax Assets, Property, Plant and Equipment USD 49,000 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 6.49M 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 1.51M 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsReserves Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Reserves USD 1.52M 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 87.18M 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 700,000 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD -700,000 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap DeferredTaxLiabilitiesPropertyPlantAndEquipment Deferred Tax Liabilities, Property, Plant and Equipment USD 0 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap DepositAssets Deposit Assets USD 100.00B 2024-02-13 2025 Q2 10-Q 2025-08-01 0001213900-25-070659
us-gaap Depreciation Depreciation USD 226,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap DirectOperatingCosts Direct Operating Costs USD 66,701 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0001213900-24-043582
us-gaap DividendsPayableCurrentAndNoncurrent Dividends Payable USD 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares -1.66 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares -1.66 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.21 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure -0.217 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap EffectiveIncomeTaxRateReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Percent pure -0.005 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap EffectiveIncomeTaxRateReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Percent pure -0.009 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap EffectiveIncomeTaxRateReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Percent pure 0.002 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure 0 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0.019 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 61.50M 2026-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-219829
us-gaap ExpenseRelatedToDistributionOrServicingAndUnderwritingFees Expense Related to Distribution or Servicing and Underwriting Fees USD 1.84M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0001213900-24-043582
us-gaap FinanceLeaseRightOfUseAssetAmortization Finance Lease, Right-of-Use Asset, Amortization USD 330,000 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 25.23M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 29.13M 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 625,000 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -28.15M 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 1.18M 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -284,000 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 0 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 2.50M 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD 8.89M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 2.40M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-01 0001213900-25-070659
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD 111,690 2024-01-01 2024-09-30 2024 Q3 10-Q 2024-11-14 0001213900-24-098483
us-gaap IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities USD 6.73M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap IncreaseDecreaseInDueFromRelatedParties Increase (Decrease) in Due from Related Parties USD 72,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap IncreaseDecreaseInDueToRelatedPartiesCurrent Increase (Decrease) in Due to Related Parties, Current USD 38,748 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-01 0001213900-25-070659
us-gaap IncreaseDecreaseInEmployeeRelatedLiabilities Increase (Decrease) in Employee Related Liabilities USD -479,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD -386,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap IncreaseDecreaseInOtherAccruedLiabilities Increase (Decrease) in Other Accrued Liabilities USD 122,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 935,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap IncreaseDecreaseInParticipationLiabilities Increase (Decrease) in Participation Liabilities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 7.75M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap IncreaseDecreaseInProfessionalFeePayable IncreaseDecreaseInProfessionalFeePayable USD 1.10M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap InterestIncomeOperating Interest Income, Operating USD 10.76M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap InvestmentBankingRevenue Investment Banking Revenue USD 3,604 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-01 0001213900-25-070659
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 4.06M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-01 0001213900-25-070659
us-gaap InvestmentsAndCash Investments and Cash USD 200.00M 2025-06-30 2025 Q2 10-Q 2025-08-01 0001213900-25-070659
us-gaap LegalFees Legal Fees USD 12.40M 2025-01-01 2025-12-31 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap LesseeOperatingLeaseLiabilityPaymentsDue Lessee, Operating Lease, Liability, to be Paid USD 2.71M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths Lessee, Operating Lease, Liability, to be Paid, Year One USD 730,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFive Lessee, Operating Lease, Liability, to be Paid, Year Five USD 263,000 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearFour Lessee, Operating Lease, Liability, to be Paid, Year Four USD 263,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearThree Lessee, Operating Lease, Liability, to be Paid, Year Three USD 782,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap LesseeOperatingLeaseLiabilityPaymentsDueYearTwo Lessee, Operating Lease, Liability, to be Paid, Year Two USD 755,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year USD 178,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap LesseeOperatingLeaseLiabilityUndiscountedExcessAmount Lessee, Operating Lease, Liability, Undiscounted Excess Amount USD 327,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap Liabilities Liabilities USD 52.84M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 346.22M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 0 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap LiabilitiesCurrent Liabilities, Current USD 51.03M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap MandatorilyRedeemablePreferredStockFairValueDisclosure Mandatorily Redeemable Preferred Stock, Fair Value Disclosure USD 3.80M 2025-04-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap MarketableSecurities Marketable Securities USD 238.85M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap MarketableSecuritiesCurrent Marketable Securities, Current USD 117.39M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap MarketableSecuritiesNoncurrent Marketable Securities, Noncurrent USD 121.46M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap MarketableSecuritiesUnrealizedGainLoss Marketable Securities, Unrealized Gain (Loss) USD -1.71M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 774,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD -189.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -108.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -132.74M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1 Noncash or Part Noncash Acquisition, Value of Assets Acquired USD 0 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 11.12M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap NotesPayable Notes Payable USD 300,000 2021-06-19 2025 Q2 10-Q 2025-08-01 0001213900-25-070659
us-gaap NotesPayableCurrent Notes Payable, Current USD 716,000 2026-03-31 2026 Q1 10-Q 2026-05-12 0001193125-26-219829
us-gaap NumberOfOperatingSegments Number of Operating Segments Segment 1 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-01 0001213900-25-070659
us-gaap OperatingExpenses Operating Expenses USD 143.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -143.85M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap OperatingLeaseLiability Operating Lease, Liability USD 2.38M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 571,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 1.81M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 1.99M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.074 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap OperatingLossCarryforwardsValuationAllowance Operating Loss Carryforwards, Valuation Allowance USD 148.80M 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 362,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 13.50M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -145,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap OtherNotesPayable Other Notes Payable USD 0 2024-12-31 2024 FY 10-K 2025-03-11 0001213900-25-022387
us-gaap OtherSignificantNoncashTransactionValueOfConsiderationReceived1 Other Significant Noncash Transaction, Value of Consideration Received USD 0 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap OtherUnderwritingExpense Other Underwriting Expense USD 5.52M 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-01 0001213900-25-070659
us-gaap ParticipatingMortgageLoansParticipationLiabilitiesAmount Participating Mortgage Loans, Participation Liabilities, Amount USD 0 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap PaymentOfFinancingAndStockIssuanceCosts Payment of Financing and Stock Issuance Costs USD 121,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap PaymentsForOtherOperatingActivities Payments for Other Operating Activities USD 3.00M 2024-05-01 2024-05-31 2026 Q1 10-Q 2026-05-12 0001193125-26-219829
us-gaap PaymentsForParticipationLiabilities Payments for Participation Liabilities USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap PaymentsForRepurchaseOfInitialPublicOffering Payments for Repurchase of Initial Public Offering USD 578,550 2024-01-01 2024-06-30 2025 Q2 10-Q 2025-08-01 0001213900-25-070659
us-gaap PaymentsForUnderwritingExpense Payments for Underwriting Expense USD 3.25M 2024-02-13 2025 Q2 10-Q 2025-08-01 0001213900-25-070659
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 578,550 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0001213900-24-043582
us-gaap PaymentsToAcquireMarketableSecurities Payments to Acquire Marketable Securities USD 336.13M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 84,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap PaymentsToInvestInDecommissioningFund Payments to Acquire Investments to be Held in Decommissioning Trust Fund USD 184.00M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0001213900-24-043582
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 14.30M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 11,307 2024-06-30 2024 Q2 10-Q 2024-08-14 0001213900-24-068630
us-gaap PrepaidExpenseNoncurrent Prepaid Expense, Noncurrent USD 212,508 2024-03-31 2024 Q1 10-Q 2024-05-15 0001213900-24-043582
us-gaap PrepaidInsurance Prepaid Insurance USD 150,048 2025-06-30 2025 Q2 10-Q 2025-08-01 0001213900-25-070659
us-gaap PrepaidTaxes Prepaid Taxes USD 63,750 2025-03-31 2025 Q1 10-Q 2025-05-15 0001213900-25-044424
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 112.30M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap ProceedsFromIssuanceOfConvertiblePreferredStock Proceeds from Issuance of Convertible Preferred Stock USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap ProceedsFromIssuanceOfRedeemableConvertiblePreferredStock Proceeds from Issuance of Redeemable Convertible Preferred Stock USD 0 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap ProceedsFromLeasePayments Proceeds from Lease Payment, Operating Activity USD 500,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 182.16M 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0001213900-24-043582
us-gaap ProceedsFromPartnershipContribution Proceeds from Partnership Contribution USD 0 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap ProceedsFromPaymentsForLongTermLoansForRelatedParties Proceeds from Collection of (Payments to Fund) Long-term Loans to Related Parties USD 0 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap ProceedsFromSaleAndMaturityOfMarketableSecurities Proceeds from Sale and Maturity of Marketable Securities USD 146.87M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 931,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap ProfessionalAndContractServicesExpense Professional and Contract Services Expense USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap ProfessionalFees Professional Fees USD 100,000 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 815,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 144,000 2025-02-08 2025 Q2 10-Q 2025-08-01 0001213900-25-070659
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 209,853 2024-01-01 2024-03-31 2024 Q1 10-Q 2024-05-15 0001213900-24-043582
us-gaap RepaymentsOfOtherDebt Repayments of Other Debt USD 3.00M 2025-07-01 2025-09-30 2026 Q1 10-Q 2026-05-12 0001193125-26-219829
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 209,853 2024-01-01 2024-06-30 2025 Q2 10-Q 2025-08-01 0001213900-25-070659
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 118.62M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap RestrictedCash Restricted Cash USD 132,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 408.87M 2025-09-30 2025 Q3 10-Q 2025-11-12 0001193125-25-277834
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 132,000 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap RestrictedInvestmentsPercentOfNetAssets Restricted Investments, Percent of Net Assets pure 0.2 2025-06-30 2025 Q2 10-Q 2025-08-01 0001213900-25-070659
us-gaap RestrictedStockValueSharesIssuedNetOfTaxWithholdings Restricted Stock, Value, Shares Issued Net of Tax Withholdings USD 36,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -489.30M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap SaleOfStockConsiderationReceivedOnTransaction Sale of Stock, Consideration Received on Transaction USD 260.90M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap SaleOfStockNumberOfSharesIssuedInTransaction Sale of Stock, Number of Shares Issued in Transaction shares 24.34M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 10 2025-06-30 2025 Q2 10-Q 2025-08-01 0001213900-25-070659
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 15.84M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardAcceleratedVestingNumber Share-based Compensation Arrangement by Share-based Payment Award, Accelerated Vesting, Number shares 1.73M 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-11 0001193125-26-344661
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested USD 36,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.038 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfAdditionalSharesAuthorized Share-based Compensation Arrangement by Share-based Payment Award, Number of Additional Shares Authorized shares 2.40M 2024-02-13 2024 Q1 10-Q 2024-05-15 0001213900-24-043582
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 12.23M 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.68M 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 5.25 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period shares 347,344 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price USD/shares 5.54 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 5.75M 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 6.45 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedOptionsForfeitedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Nonvested Options Forfeited, Weighted Average Grant Date Fair Value USD/shares 6.49 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Option, Nonvested, Weighted Average Exercise Price USD/shares 35.9 2025-09-30 2025 Q3 10-Q 2025-11-12 0001193125-25-277834
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 42.77M 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 9.04M 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 7.79 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 4.78 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost Share-based Payment Arrangement, Plan Modification, Incremental Cost USD 2.00M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 4.39 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 2.85 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-12 0001193125-25-277834
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 9.9 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap SharePrice Share Price USD/shares 8.855 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 10 2024-02-13 2024 Q1 10-Q 2024-05-15 0001213900-24-043582
us-gaap ShortTermLeaseCost Short-term Lease, Cost USD 600,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap StockGrantedDuringPeriodValueSharebasedCompensation Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture USD 1.10M 2024-05-01 2024-05-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 293.39M 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 222,939 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-11 0001193125-26-344661
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 189,000 2025-01-01 2025-03-31 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecuritiesNetOfAdjustments Stock Issued During Period, Value, Conversion of Convertible Securities, Net of Adjustments USD 349.22M 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 5.09M 2024-01-01 2024-03-31 2025 Q2 10-Q 2025-08-01 0001213900-25-070659
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 478,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap TaxesPayableCurrentAndNoncurrent Taxes Payable USD 100,000 2024-03-31 2024 Q1 10-Q 2024-05-15 0001213900-24-043582
us-gaap TemporaryEquityAccretionToRedemptionValue Temporary Equity, Accretion to Redemption Value USD 2.07M 2025-04-01 2025-06-30 2025 Q2 10-Q 2025-08-01 0001213900-25-070659
us-gaap TemporaryEquityAccretionToRedemptionValueAdjustment Temporary Equity, Accretion to Redemption Value, Adjustment USD 16.61M 2024-01-01 2024-12-31 2024 FY 10-K 2025-03-11 0001213900-25-022387
us-gaap TemporaryEquityCarryingAmountAttributableToParent Temporary Equity, Carrying Amount, Attributable to Parent USD 185.21M 2024-03-31 2024 Q1 10-Q 2024-05-15 0001213900-24-043582
us-gaap TemporaryEquitySharesIssued Temporary Equity, Shares Issued shares 30,000 2023-11-29 2024 Q1 10-Q 2024-05-15 0001213900-24-043582
us-gaap UnrealizedGainLossOnInvestments Unrealized Gain (Loss) on Investments USD 0 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 2.16M 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap UnrecognizedTaxBenefitsDecreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Decrease Resulting from Current Period Tax Positions USD 4,000 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense USD 0 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions USD 855,000 2025-01-01 2025-12-31 POS AM 2026-04-30 0001193125-26-197901
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 80.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 80.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-10 0001193125-26-455521

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →